Advertisement
Advertisement

BLTE

BLTE logo

Belite Bio, Inc - ADR

158.87
USD
Sponsored
-2.19
-1.36%
Aug 24, 15:58 UTC -4
Closed
exchange

After-Market

157.83

-1.04
-0.65%

Belite Bio, Inc - ADR Profile

About

Belite Bio Inc. is a clinical stage biopharmaceutical drug development company focused on novel therapeutics targeting currently untreatable eye diseases involving retinal degeneration, such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease, and metabolic diseases. Belite Bio Inc. is based in SAN DIEGO.

Info & Links

CEO

Yu-Hsin Lin

Headquarters

12750 HIGH BLUFF DRIVE SUITE 475
SAN DIEGO, CA 92130, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.belitebio.com

Auditor

Deloitte & Touche

Share holders

--

Employees

23

Belite Bio, Inc - ADR Statistics

Valuation Measures

Market Capitalization2

6.36B

Enterprise Value

6.36B

Enterprise Value/EBITDA(ttm)

-53.61

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

8.31

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-11.84%

Return on Invested Capital(ttm)

-18.24%

Return on Assets(ttm)

-11.62%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-118.57M

Net Income Available to Common(ttm)

-102.36M

Diluted EPS(ttm)

-2.73

Share Statistics

Beta (5Y Monthly)

-1.22

52-Week Change

146.69%

S&P 500 52-Week Change

18.66%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

34.76M

% Held by Insiders

13.29%

% Held by Institutions

0.53%

Balance Sheet

Total Cash(mrq)

0.00

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

33.56%

Quick Ratio(mrq)

33.56%

Book Value Per Share(mrq)

19.28

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement